RankAlpha logo
Back to Rankings

IQV

IQVIAC
NYSE / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-18
View Chart
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
IQV vs peer average
49/100
IQV vs. peer average (C vs. C)
Grade spread
A 1 · B 2 · C 5 · D 3
Graded peers loaded
Coverage
11 graded
100% of tracked

Peer overview

ICLR is the first available peer comparator.

ICON is a direct global CRO competitor identified in IQVIA's competitive disclosures; IQVIA's relative case depends on combining CRO scale with commercial data and analytics rather than winning on pure trial-execution growth alone [#10-K-2026-02-17].

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerICLRICON
IQV
IQVIA
ICLR
ICON
Grade
C
C
Momentum
51
81
Value
66
67
Sentiment
36
9
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Mixed
Open Side-by-Side ComparisonCompare all

Grade position vs ICLR

IQV / ICLR
Grade Position
In line
IQV vs. peer average (C vs. C)
49/100
Momentum
51
ICLR
Value
66
ICLR
Sentiment
36
IQV

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs IQV
1
ICLR
ICLR
C
60/100
Even
2
FTRE
FTRE
B
80/100
-1
3
TMO
TMO
B
80/100
-1
4
RPRX
Royalty Pharma Plc Class A Common
D
40/100
+1
5
ALNY
Alnylam Pharmaceuticals Inc Common
A
100/100
-2
ICLR is the first peer returned for this comparison set.